Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GN3E
|
|||
| Former ID |
DNC003838
|
|||
| Drug Name |
3-(1H-Indol-3-yl)-quinoline
|
|||
| Synonyms |
3-(1H-indol-3-yl)quinoline; CHEMBL309116; 3-(1H-Indol-3-yl)-quinoline; 3-(3-Quinolyl)-1H-indole; SCHEMBL8171583; ZINC13737696; BDBM50039096
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12N2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C=C(C=N2)C3=CNC4=CC=CC=C43
|
|||
| InChI |
1S/C17H12N2/c1-3-7-16-12(5-1)9-13(10-18-16)15-11-19-17-8-4-2-6-14(15)17/h1-11,19H
|
|||
| InChIKey |
BJQHKICYZOBROI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J Med Chem. 1994 Jul 8;37(14):2129-37. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.